Recent Finacing
Recent Raise
CellAegis Devices develops a patented non-invasive autoRIC device delivering Remote Ischemic Conditioning therapy for ischemia–reperfusion injury, holding CE Mark and Health Canada approvals and pursuing U.S. trials and 510(k) clearance.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors